Author:
Amoaku W, ,Blakeney S,Freeman M,Gale R,Johnston R,Kelly S P,McLaughlan B,Sahu D,Varma D
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR . How big is the burden of visual loss caused by age related macular degeneration in the United Kingdon? B J Ophthalmol 2003; 87: 312–317.
2. Bunce C, Wormald R . Causes of blind certifications in England and Wales: April 1999-March 2000. Eye 2008; 22: 905–911.
3. NICE Technology Appraisal Guidance TA155. Ranibizumab and pegaptanib for the treatment of age-related macular degeneration. 2008. Accessed at
http://www.nice.org.uk/nicemedia/pdf/TA155guidance.pdf
.
4. Congdon N, O’Colmain B, Klaver CCW, Klein R, Munoz B, Friedman DS et al. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004; 122: 477–485.
5. Bressler NM, Arnold J, Barbazetto I, Birngruber R, Blumenkranz MS, Bressler SB et al. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 2001; 119: 198–207.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献